Effects of morphine withdrawal syndrome on endooligopeptidase (ec 3.4.22.19) activity (1994)
Source: European Journal of Pharmacology. Unidades: ICB, FFCLRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAIK, S H et al. Effects of morphine withdrawal syndrome on endooligopeptidase (ec 3.4.22.19) activity. European Journal of Pharmacology, v. 253, n. 1-2, p. 101-6, 1994Tradução . . Disponível em: https://doi.org/10.1016/0014-2999(94)90763-3. Acesso em: 09 jun. 2024.APA
Paik, S. H., Camarao, G. C., Bauer, J. A., Leite, P. E. P., Oliveira, E. S., Camargo, A. C. M. de, & Farges, R. C. (1994). Effects of morphine withdrawal syndrome on endooligopeptidase (ec 3.4.22.19) activity. European Journal of Pharmacology, 253( 1-2), 101-6. doi:10.1016/0014-2999(94)90763-3NLM
Paik SH, Camarao GC, Bauer JA, Leite PEP, Oliveira ES, Camargo ACM de, Farges RC. Effects of morphine withdrawal syndrome on endooligopeptidase (ec 3.4.22.19) activity [Internet]. European Journal of Pharmacology. 1994 ;253( 1-2): 101-6.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/0014-2999(94)90763-3Vancouver
Paik SH, Camarao GC, Bauer JA, Leite PEP, Oliveira ES, Camargo ACM de, Farges RC. Effects of morphine withdrawal syndrome on endooligopeptidase (ec 3.4.22.19) activity [Internet]. European Journal of Pharmacology. 1994 ;253( 1-2): 101-6.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/0014-2999(94)90763-3
